DEF 14ADARECIK 0001401914

Dare Bioscience, Inc.

Name: SEC EDGAR filing 0001493152-26-045977
Creator: Dare Bioscience, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed October 6, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001493152-26-045977
Filer: Dare Bioscience, Inc.
Ticker: DARE
CIK: 0001401914
Form type: DEF 14A
Form description: Proxy statement
Filed at: October 6, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 7, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Dare Bioscience, Inc.

PRE 14ASEC filingSep 23, 2026

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1401914/000149315226045977/0001493152-26-045977-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Dare Bioscience, Inc. (0001401914) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001493152-26-045977.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.